Kos-Kudła Beata, Hubalewska-Dydejczyk Alicja, Kuśnierz Katarzyna, Lampe Paweł, Marek Bogdan, Nasierowska-Guttmejer Anna, Nowakowska-Duława Ewa, Pilch-Kowalczyk Joanna, Sowa-Staszczak Anna, Rosiek Violetta
Division of Endocrinology, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
Endokrynol Pol. 2013;64(6):459-79. doi: 10.5603/EP.2013.0031.
We present revised diagnostic and therapeutic guidelines for the management of pancreatic neuroendocrine neoplasms (PNENs) proposed by the Polish Network of Neuroendocrine Tumours.These guidelines refer to biochemical (determination of specific and nonspecific neuroendocrine markers) and imaging diagnostics (EUS, CT, MR, and radioisotope examination with a 68Ga or 99Tc labelled somatostatin analogue).A histopathological diagnostic, which determines the further management of patients with PNENs, must be necessarily confirmed by immunohistochemical tests. PNENs therapy requires collaboration between a multidisciplinary team of specialists experienced in the management of these neoplasms. Surgery is the basic form of treatment. Medical therapy requires a multidirectional procedure, and therefore the rules of biotherapy, peptide receptor radionuclide therapy, chemotherapy and molecular targeted therapy are discussed.
我们展示了由波兰神经内分泌肿瘤网络提出的关于胰腺神经内分泌肿瘤(PNENs)管理的修订诊断和治疗指南。这些指南涉及生化诊断(特定和非特定神经内分泌标志物的测定)和影像诊断(超声内镜检查、计算机断层扫描、磁共振成像以及使用68Ga或99Tc标记的生长抑素类似物的放射性同位素检查)。组织病理学诊断决定了PNENs患者的进一步治疗方案,必须通过免疫组织化学检测来确认。PNENs的治疗需要一个在这些肿瘤管理方面经验丰富的多学科专家团队协作。手术是基本的治疗形式。药物治疗需要多方面的程序,因此讨论了生物治疗、肽受体放射性核素治疗、化疗和分子靶向治疗的规则。